Outpatient CAR T-Cell Therapy as Standard of Care: Current Perspectives and Considerations
{{output}}
Chimeric antigen receptor T-cell therapy (CAR-T) has altered the treatment landscape of several hematologic malignancies. Until recently, most CAR-T infusions have been administered in the inpatient setting, due to their toxicity profile. However, the advent o... ...
